Determinant Flanking Regions and the Design of Appropriate Vaccines
- 1 May 1995
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 754 (1 Combined) , 48-56
- https://doi.org/10.1111/j.1749-6632.1995.tb44437.x
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Vaccination of the Leishmania major susceptible BALB/c mouse. I. The precise selection of peptide determinant influences CD4+ T cell subset expressionInternational Immunology, 1994
- Dominant determinants in hen eggwhite lysozyme correspond to the cryptic determinants within its self-homologue, mouse lysozyme: implications in shaping of the T cell repertoire and autoimmunity.The Journal of Experimental Medicine, 1993
- Determinant capture as a possible mechanism of protection afforded by major histocompatibility complex class II molecules in autoimmune disease.The Journal of Experimental Medicine, 1993
- Dominance and Crypticity of T Cell Antigenic DeterminantsAnnual Review of Immunology, 1993
- Rules for Peptide Presentation by MHC Class II MoleculesInternational Reviews of Immunology, 1993
- Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in sizeNature, 1992
- Subjugation of dominant immunogenic determinants within a chimeric peptideEuropean Journal of Immunology, 1992
- T cell determinant structure: cores and determinant envelopes in three mouse major histocompatibility complex haplotypes.The Journal of Experimental Medicine, 1991
- Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapyCell, 1989
- Th1 And Th2 Cells: Different Patterns Of Lymphokine Secretion Lead To Different Functional PropertiesAnnual Review of Immunology, 1989